Neumora Therapeutics, Inc.（以下简称“Neumora”）近日正式披露了2025年第四季度及全年的财务报告，并同步更新了公司最新业务动态。此次公布的信息涵盖了公司在财务表现、研发进展及战略规划方面的关键内容，为投资者及市场关注者提供了全面的运营概览。
Neumora Therapeutics, Inc.（以下简称“Neumora”）近日正式披露了2025年第四季度及全年的财务报告，并同步更新了公司最新业务动态。此次公布的信息涵盖了公司在财务表现、研发进展及战略规划方面的关键内容，为投资者及市场关注者提供了全面的运营概览。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.